Seroconversion of SARS-CoV-2 infected patients on immunosuppression: a retrospective analysis
Published in Journal of the American Academy of Dermatology
Published in Journal of the American Academy of Dermatology
Published in Journal of the American Academy of Dermatology
Published in Journal of the American Academy of Dermatology
Published in Journal of the American Academy of Dermatology
Published in Journal of the American Academy of Dermatology
Published in Journal of the American Academy of Dermatology
Published in Journal of the American Academy of Dermatology
Published in Journal of the American Academy of Dermatology
Published in Journal of the American Academy of Dermatology
Published in Journal of the American Academy of Dermatology
The safety and efficacy of SARS-CoV-2 vaccines in patients with immune-mediated dermatologic diseases requiring immunotherapeutics is unknown. The SARS-CoV-2 vaccines approved and distributed are expected to be safe for patients on immunotherapeutics with some variability in efficacy, depending on the degree of immunosuppression and type of vaccine...